type
interferon
ifn
innat
cytokin
potent
antivir
immunoregulatori
activ
remain
unclear
human
cytomegaloviru
hcmv
establish
persist
face
strongli
antagonist
cytokin
studi
confirm
effici
suppress
penetr
hcmv
suscept
cell
includ
monocyt
major
cell
popul
peripher
blood
highli
suscept
hcmv
infect
demonstr
hcmvderiv
interleukin
homolog
function
similar
cellular
broadli
inhibit
tlrinduc
transcript
activ
gene
plasmacytoid
dendrit
cell
pdc
major
type
ifnproduc
vivo
highli
resist
hcmv
infect
vitro
result
suggest
hcmv
subvert
innat
immun
suppress
type
ifn
product
pdc
primari
viral
infect
via
homolog
upon
primari
viral
infect
innat
immun
mechan
rapidli
counteract
viral
attack
prolong
inflammatori
respons
onset
sever
tissu
damag
jeopard
health
andor
surviv
host
type
interferon
ifn
consist
singl
gene
famili
gene
among
other
long
consid
import
effector
cytokin
inhibit
viral
replic
induc
host
gene
oligoadenyl
synthetas
mxa
dsrnaactiv
protein
kinas
stark
et
al
vilcek
sen
moreov
type
ifn
also
play
import
role
immunoregul
activ
natur
killer
nk
cell
krug
et
al
modul
function
dendrit
cell
dc
lapenta
et
al
longman
et
al
b
cell
aichel
et
al
chang
et
al
coro
chang
baumgarth
le
bon
et
al
well
finetun
dc
develop
bone
marrow
zuniga
et
al
plasmacytoid
dendrit
cell
pdc
uniqu
dc
popul
regul
innat
adapt
antivir
immun
colonna
trinchieri
liu
although
cell
produc
type
ifn
pdc
produc
cell
type
respons
viral
infect
cella
et
al
kadowaki
et
al
siegal
et
al
pdc
migrat
blood
lymphoid
tissu
secret
high
level
activ
compon
immun
system
siegal
et
al
pdc
react
specif
viral
compon
via
subset
tolllik
receptor
tlr
gilliet
cao
liu
express
bind
genom
rna
virus
influenza
vesicular
stomat
viru
diebold
et
al
lund
et
al
bind
unmethyl
cpg
residu
dna
virus
herpesvirus
krug
et
al
lund
et
al
signal
adaptor
molecul
recruit
signal
mediat
activ
takeda
kaisho
akira
acut
mous
cytomegaloviru
mcmv
infect
product
pdc
blood
spleen
depend
signal
pathway
delal
et
al
krug
et
al
mice
posit
feedback
loop
initi
induct
rapid
phosphoryl
interferon
regulatori
factor
transcript
factor
constitut
express
mani
cell
type
lead
accumul
subsequ
activ
express
subtyp
levi
mari
prakash
mari
durbin
levi
theofilopoulo
et
al
surprisingli
mani
virus
develop
mechan
disrupt
function
therebi
dampen
antivir
effect
type
ifn
abat
watanab
mocarski
foy
et
al
lin
et
al
ronco
et
al
talon
et
al
resist
virus
type
ifn
larg
attribut
action
viral
compon
insid
infect
cell
larg
complex
dna
virus
vaccinia
viru
orthopoxvirus
also
synthes
solubl
receptor
homolog
counteract
type
ifn
symon
alcami
smith
induct
product
occur
much
rapidli
pdc
due
constitut
express
izaguirr
et
al
prakash
et
al
intact
pdc
function
essenti
control
infect
mani
dna
rna
virus
vivo
includ
mcmv
mous
hepat
viru
respiratori
syncyti
viru
cervantesbarragan
et
al
dalod
et
al
wang
peter
schwarz
shown
pdcderiv
critic
nk
cell
cytotox
mcmv
infect
dalod
et
al
le
bon
et
al
nguyen
et
al
therefor
particular
interest
determin
whether
human
cytomegaloviru
hcmv
also
suppress
type
ifn
product
pdc
vitro
data
demonstr
although
pdc
highli
resist
hcmv
penetr
capac
initi
robust
type
ifn
respons
markedli
reduc
elabor
viral
homolog
hcmvinfect
cell
result
establish
anoth
aspect
complex
multipot
immunomodulatori
function
hcmv
fulli
assess
potenti
target
hcmv
infect
blood
use
endotheli
epitheli
cell
tropic
hcmv
wang
shenk
wang
shenk
infect
freshli
isol
pbmc
hcmv
variant
contain
intact
region
encod
open
read
frame
crucial
leukotrop
hcmv
hahn
et
al
egfp
express
cassett
driven
constitut
promot
h
post
infect
fac
analysi
conduct
determin
frequenc
infect
cell
ident
predomin
hcvminfect
cell
popul
monocyt
data
shown
consist
previou
report
soderberg
et
al
addit
small
fraction
nonb
nont
cell
also
becam
egfp
suggest
cell
either
infect
hcmv
engulf
cell
compon
infect
cell
data
shown
previou
report
show
monocytederiv
dc
modc
also
suscept
hcmv
infect
beck
et
al
moutaftsi
et
al
riegler
et
al
therefor
focus
hcmv
infect
two
major
primari
dc
subset
human
blood
myeloid
dc
pdc
liu
monocyt
myeloid
dc
pdc
separ
isol
individu
donor
monocyt
dc
pdc
inocul
hcmv
variou
multipl
infect
moi
calcul
accord
infect
titer
fibroblast
cell
collect
immunostain
conjug
monoclon
antibodi
hladr
h
post
inocul
identifi
infect
cell
flow
cytometri
use
egfp
signal
egfpexpress
hcmv
driven
constitut
promot
purifi
monocyt
dc
show
differ
degre
suscept
hcmv
infect
surfac
express
mhcii
cell
popul
increas
infect
fig
also
note
cell
type
less
suscept
hcmv
infect
fibroblast
averag
monocyt
dc
respect
becam
egfp
infect
viru
dose
caus
infect
close
fibroblast
contrast
pdc
far
resist
hcmv
infect
monocyt
myeloid
dc
isol
pdc
infect
hcmv
moi
titer
infect
monocyt
small
fraction
pdc
infect
hcmv
fig
although
egfp
fluoresc
direct
indic
viru
replic
find
strong
pdc
resist
hcmv
infect
accord
report
use
differ
hcmv
strain
detect
system
cederarv
soderbergnaucl
odeberg
kvale
et
al
varani
et
al
sinc
pdc
strong
produc
next
determin
whether
presenc
type
ifn
could
directli
inhibit
entri
hcmv
suscept
cell
type
pretreat
monolay
fibroblast
epitheli
cell
well
purifi
monocyt
differ
concentr
recombin
h
hcmv
infect
cell
exhibit
differ
suscept
hcmv
attachmententri
achiev
similar
level
viral
infect
among
differ
cell
type
cell
inocul
moi
monocyt
inocul
moi
presenc
significantli
reduc
overal
frequenc
infect
cell
dosedepend
manner
fig
low
dose
uml
provid
profound
reduct
viral
entri
observ
epitheli
cell
reduct
monocyt
averag
reduct
two
donor
comparison
fibroblast
reduct
togeth
similar
find
dc
kvale
et
al
data
suggest
type
ifnrmedi
signal
directli
inhibit
viral
entri
adher
cell
also
major
hcmv
target
peripher
blood
previous
show
hcmv
encod
homolog
inhibit
matur
modc
alter
cytokin
profil
chang
et
al
studi
aim
examin
whether
would
also
impair
pdc
mimic
secret
follow
hcmv
infect
pbmc
treat
condit
media
fibroblast
cultur
infect
wildtyp
hcmv
knockout
variant
addit
medium
alon
induc
detect
level
secret
pbmc
despit
presenc
viral
particl
condit
media
hcmv
strain
data
shown
therefor
ad
aclass
cpg
induc
strong
product
pbmc
supernat
pbmc
cultur
collect
stimul
h
analyz
elisa
protein
medium
significantli
suppress
induct
secret
compar
control
medium
fig
contrast
condit
medium
collect
defect
mutant
hcmv
cultur
enhanc
cpginduc
product
level
significantli
higher
control
group
ng
ml
recombin
introduc
cultur
dose
equival
level
hcmvencod
condit
medium
chang
et
al
wildtyp
phenotyp
medium
restor
fig
thu
supernat
viru
express
lack
could
suppress
product
directli
test
effect
product
pbmc
treat
purifi
recombin
protein
cell
stimul
aclass
cpg
heatinactiv
influenza
viru
doucett
et
al
parallel
cultur
establish
human
compar
potenc
result
show
significantli
suppress
pdcderiv
product
dosedepend
fashion
fig
littl
ngml
suffici
reduc
product
use
approxim
equimolar
concentr
show
similarli
effect
suppress
type
ifn
secret
data
establish
infectioninduc
could
inhibit
product
pbmc
next
investig
whether
reduc
secret
act
directli
pdc
hcmv
activ
pdc
via
varani
et
al
use
agonist
aclass
cpg
stimulu
compar
effect
ngml
product
freshli
isol
primari
pdc
high
dose
cpg
ad
induc
averag
pgml
pgml
secret
pdc
isol
individu
donor
neither
inhibit
cpginduc
matur
pdc
determin
increas
express
mhcii
fig
statist
analys
demonstr
significantli
alter
express
level
surfac
molecul
tabl
howev
markedli
suppress
product
averag
fig
similar
trend
observ
follow
stimul
pdc
ligand
heatinactiv
influenza
viru
invivogen
data
shown
determin
whether
reduct
type
ifn
caus
suppress
express
subset
type
ifn
subtyp
gene
comprehens
analysi
transcript
profil
type
ifn
gene
pdc
conduct
use
nest
multiplex
realtim
pcr
assay
szubin
et
al
effect
suppress
gene
transcript
activ
pdc
fig
moreov
broadli
reduc
steadyst
mrna
level
subtyp
fig
impact
gene
similar
reduc
express
level
instanc
threshold
detect
although
appear
slightli
stronger
suppress
effect
gene
express
subtyp
exampl
subtyp
level
transcript
low
unlik
constitut
biolog
relev
differ
particularli
small
express
differ
translat
distinguish
differ
overal
protein
level
fig
upper
panel
summari
data
confirm
expand
result
earlier
studi
chang
et
al
demonstr
high
degre
function
overlap
viral
human
impact
type
ifn
gene
regul
pdc
critic
cell
type
protect
cell
viral
infect
inhibit
viral
replic
infect
cell
optim
innat
adapt
antivir
immun
respons
broad
cell
tropism
enabl
hcmv
infect
variou
innat
immun
compon
endotheli
cell
cell
type
close
associ
cell
innat
adapt
immun
system
unlik
monocyt
myeloid
dc
suscept
pdc
hcmv
infect
low
result
suggest
hcmv
effici
quell
robust
type
ifn
antivir
respons
via
secret
target
pdc
influenc
function
blood
vessel
lymph
node
studi
demonstr
boost
resist
leukocyt
particularli
monocyt
hcmv
infect
impli
import
system
product
type
ifn
contain
viral
propag
dissemin
earli
stage
infect
current
unclear
pdc
refractori
hcmv
infect
blockad
viral
entri
seem
due
autocrin
effect
type
ifn
pdc
remain
resist
hcmv
activ
inhibit
kvale
et
al
recent
evid
suggest
monocytesmacrophag
myeloid
dc
pdc
deriv
macrophag
dc
progenitor
mdp
liu
et
al
waskow
et
al
sinc
hcmv
establish
latenc
within
common
myeloid
progenitor
cell
hahn
jore
mocarski
zhuravskaya
et
al
ie
precursor
mdp
pdc
seem
lose
suscept
hcmv
infect
matur
togeth
report
cederarv
soderbergnaucl
odeberg
varani
et
al
find
confirm
hcmv
infect
small
fraction
pdc
vitro
infect
abort
late
viral
protein
detect
infect
cell
varani
et
al
although
major
cmv
structur
protein
prevent
activ
abat
watanab
mocarski
mechan
unlik
affect
type
ifn
product
pdc
late
protein
ii
rapid
strong
induct
pdc
reli
high
constitut
express
uniqu
characterist
pdc
izaguirr
et
al
prakash
et
al
whether
hcmv
encod
gene
target
like
kaposi
sarcomaassoci
herpesviru
zhu
et
al
remain
studi
viral
homolog
releas
hcmvinfect
cell
potent
inhibit
secret
pdc
impair
phenotyp
matur
fig
tabl
thu
pdc
like
remain
function
antigenpres
cell
howev
outcom
interact
leukocyt
might
modul
produc
substanti
lower
level
type
ifn
normal
activ
pdc
broadli
assum
hcmv
enter
pdc
elicit
product
assess
whether
suppress
express
hcmvinfect
pdc
primari
isol
pdc
highli
resist
hcmv
infect
vitro
nevertheless
util
synthet
ligand
stimul
pdc
consid
biolog
relev
induct
product
cmv
infect
shown
depend
pathway
mediat
vivo
delal
et
al
krug
et
al
demonstr
cellular
equal
potent
suppress
entir
spectrum
gene
express
pdc
known
induc
cell
death
cpgactiv
pdc
duramad
et
al
rissoan
et
al
data
indic
reduct
type
ifn
secret
may
larg
attribut
suppress
type
ifn
gene
transcript
impair
product
along
moder
reduct
express
chang
et
al
may
synergist
contribut
cell
death
known
autocrin
surviv
factor
activ
pdc
kadowaki
et
al
summari
studi
show
secret
hcmvinfect
cell
directli
broadli
affect
type
ifn
product
pdc
provid
anoth
exampl
hcmv
establish
chronic
infect
despit
presenc
fulli
function
immun
surveil
host
compromis
systemicloc
product
pleiotrop
may
facilit
dissemin
hcmv
primari
infect
suppress
effect
antivir
immun
wellorchestr
type
ifn
network
disrupt
may
late
boost
resist
target
cell
hcmv
infect
promot
activ
nk
cell
dc
b
cell
cell
allow
hcmv
establish
persist
human
embryon
lung
fibroblast
purchas
american
type
cultur
collect
atcc
cultur
complet
dmem
invitrogen
chang
et
al
human
retin
pigment
epitheli
cell
purchas
atcc
cultur
complet
rpe
medium
supplement
fetal
calf
serum
mm
lglutamin
u
penicillinml
streptomycinml
mm
sodium
pyruv
mm
mem
nonessenti
amino
acid
hepe
invitrogen
hcmv
strain
knockout
variant
yu
silva
shenk
use
studi
gener
hcmvinfect
condit
medium
condit
medium
prepar
describ
previous
chang
et
al
brief
cultur
infect
moi
supernat
collect
seven
day
later
filter
filter
store
c
use
endotheli
epitheli
cell
tropic
variant
hcmv
wang
shenk
wang
shenk
use
monitor
hcmv
infect
stock
use
experi
propag
purifi
highspe
centrifug
chang
et
al
titrat
leukocyteenrich
buffi
coat
healthi
individu
without
donor
identifi
obtain
stanford
blood
center
pbmc
isol
ficollpaqu
ge
healthcar
gradient
centrifug
monocyt
dc
pdc
posit
select
use
microbead
cell
isol
kit
respect
miltenyi
biotec
automac
separ
program
recommend
manufactur
chang
et
al
reanalysi
monocyt
dc
pdc
show
puriti
respect
human
pbmc
isol
leukocyt
stain
directli
conjug
mab
hlrdr
purchas
bd
bioscienc
phenotyp
analysi
data
acquisit
done
use
facscalibur
facsaria
bd
bioscienc
data
analysi
illustr
done
use
flowjo
softwar
tree
star
hcmv
infect
test
cell
pretreat
recombin
pbl
interferonsourc
h
infect
induct
type
ifn
express
pbmc
plate
concentr
cellsml
isol
pdc
plate
concentr
cellsml
activ
aclass
cpg
oligodeoxynucleotid
odn
coley
pharmaceut
group
imiquimod
invivogen
heatinactiv
influenza
viru
equival
moi
treatment
recombin
r
system
ad
cultur
concomitantli
appropri
stimuli
total
rna
pdc
isol
use
rneasi
mini
kit
qiagen
treatment
h
rna
process
cdna
synthesi
perform
describ
previous
chang
et
al
steadi
state
mrna
level
subtyp
intern
control
gene
measur
quantit
realtim
pcr
describ
previous
szubin
et
al
primer
probe
sequenc
distinguish
subtyp
differ
one
nucleotid
amplifi
togeth
publish
previous
szubin
et
al
detect
mrna
outer
primer
inner
primer
probe
raw
data
normal
intern
control
gene
ubiquitin
conjug
enzym
rel
copi
number
mrna
calcul
accord
standard
curv
gener
serial
dilut
plasmid
dna
contain
amplicon
test
subtyp
quantiti
total
supernat
collect
pbmc
pdc
cultur
measur
commerci
elisa
kit
pbl
interferonsourc
follow
manufactur
instruct
verikin
human
multisubtyp
elisa
kit
specifi
measur
follow
ifn
subtyp
statist
done
oneway
anova
follow
tukey
multipl
comparison
test
dunnett
multipl
comparison
test
use
prism
softwar
graphpad
freshli
isol
blood
monocyt
left
panel
dc
middl
panel
pdc
right
panel
infect
h
gfprecombin
hcmv
moi
express
indic
surfac
marker
gfp
identifi
hcmvinfect
cell
assess
fac
shown
contour
plot
outlier
cell
gate
leukocyt
via
fscssc
identifi
monocyt
fscssc
identifi
dc
fscssc
identifi
pdc
percentag
gfp
cell
among
identifi
cell
popul
shown
plot
indic
box
number
present
mean
valu
sd
data
individu
donor
monolay
cultur
fibroblast
epitheli
cell
freshli
isol
monocyt
pretreat
indic
dose
hcmv
infect
data
repres
mean
frequenc
infect
cell
sd
triplic
quadrupl
cultur
determin
fac
statist
comparison
control
sampl
without
treatment
perform
use
oneway
anova
follow
dunnett
post
test
p
result
monocyt
repres
experi
two
individu
donor
gave
similar
result
freshli
isol
pbmc
treat
cpg
condit
medium
hcmvinfect
cultur
cpg
heatinactiv
influenza
viru
presenc
absenc
indic
concentr
ngml
b
supernat
collect
stimul
h
concentr
determin
elisa
data
repres
mean
valu
sd
statist
analysi
perform
use
oneway
anova
follow
tukey
post
test
p
dunnett
post
test
comparison
control
sampl
without
treatment
p
b
shown
repres
data
one
two
individu
donor
freshli
isol
pdc
left
untreat
stimul
cpg
presenc
absenc
ngml
h
surfac
express
indic
molecul
pdc
assess
fac
present
overlaid
histogram
shown
repres
data
one
five
individu
donor
gave
similar
result
significantli
reduc
type
ifn
product
cpgactiv
pdc
upper
panel
n
lower
panel
n
protein
concentr
supernat
measur
elisa
dot
repres
rel
concentr
cultur
compar
cpgonli
stimul
individu
donor
statist
analysi
perform
use
oneway
anova
follow
tukey
post
test
p
b
suppress
gene
express
induc
tlr
signal
shown
foldchang
gene
express
compar
untreat
cell
normal
impact
express
subtyp
cpgactiv
pdc
shown
rel
mrna
copi
number
normal
express
intern
control
gene
data
present
mean
valu
result
individu
donor
b
data
part
larg
analysi
subset
respons
pdc
publish
previous
szubin
et
al
distinguish
effect
effect
treatment
surfac
marker
express
pdc
given
concentr
ngml
upon
pdc
activ
virolog
author
manuscript
avail
pmc
august
